EP 2188297 B1 20120201 - PYRROLO [2,1-C][1, 4] BENZODIAZEPINE-GLYCOSIDE PRODRUGS USEFUL AS A SELECTIVE ANTI TUMOR AGENT
Title (en)
PYRROLO [2,1-C][1, 4] BENZODIAZEPINE-GLYCOSIDE PRODRUGS USEFUL AS A SELECTIVE ANTI TUMOR AGENT
Title (de)
ALS SELEKTIVE ANTITUMORMITTEL GEEIGNETE PYRROLO[2,1-C][1,4]BENZODIAZEPINGLYCOSID-PRODRUGS
Title (fr)
PROMÉDICAMENTS PYRROLO [2,1-C][1,4] BENZODIAZÉPINE-GLYCOSIDES UTILES COMME AGENT ANTI-TUMORAL SÉLECTIF
Publication
Application
Priority
- IN 2007000510 W 20071026
- IN 1626DE2007 A 20070801
Abstract (en)
[origin: US7754694B2] The present invention provides pyrrolo[2,1-c][1,4]benzodiazepine-glycoside prodrug of general formula 1a-b, useful as selective anticancer agents. The present invention also provides a process for the preparation of pyrrolo[2,1-c][1,4]benzodiazepine-glycoside prodrugs of general formula 1a-b. This invention also provides activation of these prodrugs by E.coli β galactosidase and envisaged that these molecules are toxic to human cancer cell lines in the presence of the enzyme E.coli β-galactosidase. The prodrugs 1a and 1b were also found to be toxic to human cancer HepG2 cells even in the absence of the E.coli β-galactosidase. The toxic effect of the molecules when activated was similar to that of the parent molecules 6a and 6b, respectively.
IPC 8 full level
C07H 15/26 (2006.01); A61K 31/7052 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61P 35/00 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07H 15/26 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2009016647 A1 20090205; AT E543826 T1 20120215; EP 2188297 A1 20100526; EP 2188297 B1 20120201; JP 2010535195 A 20101118; JP 5404624 B2 20140205; US 2009036657 A1 20090205; US 7754694 B2 20100713
DOCDB simple family (application)
IN 2007000510 W 20071026; AT 07827604 T 20071026; EP 07827604 A 20071026; JP 2010518816 A 20071026; US 1502308 A 20080116